Lord, Abbett & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $20.1M | Sell |
|
|||||
|
2022
Q2 | $21M | Buy |
|
|||||
|
2022
Q1 | $25.3M | Sell |
|
|||||
|
2021
Q4 | $73M | Buy |
|
|||||
|
2021
Q3 | $83.9M | Buy |
|
|||||
|
2021
Q2 | $57.8M | Sell |
|
|||||
|
2021
Q1 | $106M | Sell |
|
|||||
|
2020
Q4 | $167M | Buy |
|
|||||
|
2020
Q3 | $65.7M | Sell |
|
|||||
|
2020
Q2 | $74.1M | Sell |
|
|||||
|
2020
Q1 | $51.5M | Sell |
|
|||||
|
2019
Q4 | $92.5M | Buy |
|
|||||
|
2019
Q3 | $30.1M | Buy |
|
|||||
|
2019
Q2 | $38.8M | Sell |
|
|||||
|
2019
Q1 | $46.2M | Buy |
|
|||||
|
2018
Q4 | $11.3M | Buy |
|
|||||
|
2018
Q3 | $12.2M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $5.11M | Buy |
|